Average Co-Inventor Count = 3.53
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sloan-kettering Institute for Cancer Research (21 from 512 patents)
2. Columbia University (15 from 2,487 patents)
3. Other (2 from 832,680 patents)
4. Memorial Sloan Kettering Cancer Center (1 from 559 patents)
5. The Trustees of Columbia (1 from 1 patent)
27 patents:
1. 10626100 - Selective HDAC6 inhibitors
2. 9890136 - Selective HDAC6 inhibitors
3. 9539272 - HDAC 6 inhibitor-based methods for treating cancer
4. 9499479 - Molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
5. 7879865 - Treatment of cancer of the brain using histone deacetylase inhibitors
6. 7816499 - Antibodies that selectively bind HDAC9
7. 7799803 - Hydroxamic acid compounds and methods of use thereof
8. 7345174 - Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
9. 7244604 - HDAC9 polypeptides and polynucleotides and uses thereof
10. 7199134 - Hydroxamic acid compounds and methods of use thereof
11. 7126001 - Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
12. 7124068 - Crystal structure of a deacetylase and inhibitors thereof
13. 7063973 - HDAC9 polypeptides and polynucleotides and uses thereof
14. RE38506 - Potent inducers of terminal differentiation and methods of use thereof
15. 6511990 - Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof